4.5 Article

Elevated plasma endoglin (CD105) predicts decreased response and survival in a metastatic breast cancer trial of hormone therapy

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Endoglin expression in metastatic breast cancer cells enhances their invasive phenotype

D. Oxmann et al.

ONCOGENE (2008)